Comparative properties of a three-dimensional model of Plasmodium falciparum ornithine decarboxylase

Proteins: Structure, Function and Genetics

Volumn 50, Issue 3, 2003, Pages 464-473

  Birkholtz, L ^a   Joubert, F ^a   Neitz, A W H ^a   Louw, A I ^a  

^a UNIVERSITY OF PRETORIA   (South Africa)

Author keywords

Homology model; Malaria; Ornithine decarboxylase; Polyamines

Indexed keywords

ORNITHINE DECARBOXYLASE; POLYAMINE;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ARTICLE; BINDING SITE; BIOCHEMISTRY; CARBOXY TERMINAL SEQUENCE; CRYSTAL STRUCTURE; MUTAGENESIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN STRUCTURE; STRUCTURE ANALYSIS;

AMINO ACID SEQUENCE; ANIMALS; BINDING SITES; DIMERIZATION; HUMANS; IMAGING, THREE-DIMENSIONAL; LIGANDS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MOLECULAR STRUCTURE; ORNITHINE DECARBOXYLASE; PLASMODIUM FALCIPARUM; SEQUENCE ALIGNMENT;

EUKARYOTA; PLASMODIUM FALCIPARUM; TRYPANOSOMA; TRYPANOSOMA BRUCEI;

EID: 0037441470     PISSN: 08873585     EISSN: None     Source Type: Journal    
DOI: 10.1002/prot.10274     Document Type: Article

References (49)

1. Cohen SS. A guide to the polyamines. New York: Oxford University Press; 1998.
2. McCann PP, Pegg AE. Ornithine decarboxylase as an enzyme target for therapy. Pharmacol Ther 1992;54:195-215.
3. Marton LJ, Pegg AE. Polyamines as targets for therapeutic intervention. Annu Rev Pharmacol Toxicol 1995;35:55-91.
4. Wang CC. Molecular mechanisms and therapeutic approaches to the treatment of African trypanosomiasis. Annu Rev Pharmacol Toxicol 1995;35:93-127.
5. Assaraf YG, Golenser J, Spira DT, Bachrach U. Polyamine levels and the activity of their biosynthetic enzymes in human erythrocytes infected with the malaria parasite, Plasmodium falciparum. Biochem J 1984;222:815-819.
6. Assaraf YG, Golenser J, Spira DT, Messer G, Bachrach U. Cytostatic effect of DL-αμdiflouromethylornithine against Plasmodium falciparum and its reversal by diamines and spermidine. Parasitol Res 1987b;73:313-318.
7. Bitoni AJ, McCann PP, Sjoerdsma A. Plasmodium falciparum and Plasmodium berghei: effects of ornithine decarboxylase inhibitors on erythrocytic schizogony. Exp Parasitol 1987;64:237-243.
8. Bitonti AJ, Dumont JA, Bush TL, Edwards ML, Stemerick DM, McCann PP, Sjoerdsma A. Bis(benzyl)polyamine analogs inhibit the growth of chloroquine- resistant human malaria parasites (Plasmodium falciparum) in vitro and in combination with alpha-difluoromethylornithine cure murine malaria. Proc Natl Acad Sci USA 1989;86:651-655.
9. Wright PS, Cross-Doersen DE, Schroeder KK, Bowlin TL, McCann PP, Bitonti AJ. Disruption of Plasmodium falciparum-infected erythrocyte cytoadherence to human melanoma cells with inhibitors of glycoprotein processing. Biochem Pharmacol 1991;41:1855-1861.
10. Muller S, Da'dara A, Luersen K, Wrenger C, Das Gupta R, Madhubala R, Walter RD. In the human malaria parasite Plasmodium falciparum, polyamines are synthesized by a bifunctional ornithine decarboxylase, S-adenosylmethionine decarboxylase. J Biol Chem 2000;275:8097-8102.
11. Pegg AE. Characterisation of ornithine decarboxylase from various sources. In: Hayashi S, Hayashi S, editors. Ornithine decarboxylase: biology, enzymology and molecular genetics. Oxford, England: Pergamon Press, Inc.; 1989. p 21-28.
12. Almrud JJ, Oliveira MA, Kern AD, Grishin NV, Phillips MA, Hackert ML. Crystal structure of human ornithine decarboxylase at 2.1 A resolution: structural insights to antizyme binding. J Mol Biol 2000;295:7-16.
13. Grishin NV, Osterman AL, Brooks HB, Phillips MA, Goldsmith EJ. X-ray structure of ornithine decarboxylase from Trypanosoma brucei: the native structure and the structure in complex with alpha-difluoromethylornithine. Biochemistry 1999;38:15174-15184.
14. Momany C, Ernst S, Ghosh R, Chang NL, Hackert ML. Crystallographic structure of a PLP-dependent ornithine decarboxylase from Lactobacillus 30a to 3.0 A resolution. J Mol Biol 1995;252:643-655.
15. Vitali J, Carroll D, Chaudhry RG, Hackert ML. Three-dimensional structure of the Gly121Tyr dimeric form of ornithine decarboxylase from Lactobacillus 30a. Acta Crystallogr D Biol Crystallogr 1999;55:1978-1985.
16. Kern AD, Oliveira MA, Coffino P, Hackert ML. Structure of mammalian ornithine decarboxylase at 1.6 A resolution: stereo-chemical implications of PLP-dependent amino acid decarboxylases. Struct Fold Des 1999;7:567-581.
17. Ekstrom JL, Mathews II, Stanley BA, Pegg AE, Ealick SE. The crystal structure of human S-adenosylmethionine decarboxylase at 2.25 A resolution reveals a novel fold. Struct Fold Des 1999;7:583-595.
18. Baca AM, Hol WG. Overcoming codon bias: a method for highlevel over-expression of Plasmodium and other AT-rich parasite genes in Eschericia coli. Int J Parasitol 2000;30:113-118.
19. Chang SP. Expression systems to best mimick the native structure. Am J Trop Med Hyg 1994;50:20-26.
20. Srinivasan N, Guruprasad K, Blundell TL. Comparative modelling of proteins. In: Sternberg MJE, Sternberg MJE, editors. Protein structure prediction: a practical approach. Oxford: Oxford University Press; 1996.
21. Lemcke T, Christensen IT, Jorgensen FS. Towards an understanding of drug resistance in malaria: three-dimensional structure of Plasmodium falciparum dihydrofolate reductase by homology building. Bioorg Med Chem 1999;7:1003-1011.
22. Toyoda T, Brobey RK, Sano G, Horii T, Tomioka N, Itai A. Lead discovery of inhibitors of the dihydrofolate reductase domain of Plasmodium falciparum dihydrofolate reductase-thymidylate synthase. Biochem Biophys Res Commun 1997;235:515-519.
23. Warhurst DC. Antimalaria drug discovery: development of inhibitors of dihydrofolate reductase active in drug resistance. Drug Discov Today 1998;3:538-546.
24. Rastelli G, Sirawaraporn W, Sompompisut P, Vilaivan T, Kamchonwongpaisan S, Ouarrel R, Lowe G, Thebtaranonth Y, Yuthavong Y. Interaction of pyrimethamine, cycloguanil, WR99210 and their analogues with Plasmodium falciparum dihydrofolate reductase: structural basis of antifolate resistance. Bioorg Med Chem 2000;8:1117-1128.
25. Thompson JD, Higgins DG, Gibson TJ. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 1994;22:4673-4680.
26. Guex N, Peitsch MC. SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis 1997;18:2714-2723.
27. Guex N, Diemand A, Peitsch MC. Protein modelling for all. Trends Biochem Sci 1999;24:364-367.
28. Guex N, Peitsch MC. Molecular modelling of proteins. Immunol News 1999;6:132-134.
29. Peitsch MC, Tschopp J. Comparative molecular modelling of the Fas-ligand and other members of the TNF family. Mol Immunol 1995;32:761-772.
30. Peitsch MC. Protein modelling by E-mail. Bio/Technology 1995;13:658-660.
31. Peitsch MC. ProMod and Swiss-Model: internet-based tools for automated comparative protein modelling. Biochem Soc Trans 1996;24:274-279.
32. Peitsch MC, Herzyk P, Wells TN, Hubbard RE. Automated modelling of the transmembrane region of G-protein coupled receptor by Swiss-model. Receptors Channels 1996;4:161-164.
33. Huang X, Miller W. A time-efficient linear-space local similarity algorithm. Adv Appl Math 1991;12:337.
34. Vriend G. WHAT IF: a molecular modelling and drug design program. J Mol Graph 1990;8:52-56.
35. Laskowski RA, MacAthur MW, Moss DS, Thorton JM. PROCHECK: a program to check the stereochemical quality of protein structures. J Appl Crystallogr 1993;29:283-291.
36. Nicholls A, Sharp KA, Honig B. Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons. Proteins 1991;11:281-296.
37. Orengo CA, Michie AD, Jones S, Jones DT, Swindells MB, Thorton JM. CATH: a hierarchic classification of protein domain structures. Structure 1997;5:1093-1108.
38. Murzin AG, Brenner SE, Hubbard T, Chothia C. SCOP: a structural classification of proteins database for the investigation of sequences and structures. J Mol Biol 1995;247:536-540.
39. Wooton JC, Federhen S. Analysis of compositionallz baised regions in sequence databases. Methods Enzymol 1996;266:554-571.
40. Wallace AC, Laskowski RA, Thorton JM. LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions. Protein Eng 1995;8:127-134.
41. Coleman CS, Stanley BA, Pegg AE. Effects of mutations at active site residues on the activity of ornithine decarboxylase and its inhibition by active site directed irreversible inhibitors. J Biol Chem 1993;268:24572-24579.
42. Osterman A, Grishin NV, Kinch LN, Phillips MA. Formation of functional cross-species heterodimers of ornithine decarboxylase. Biochemistry 1994;33:13662-13667.
43. Pizzi E, Frontali C. Low-complexity regions in Plasmodium falciparum proteins. Genome Res 2001;11:218-229.
44. Osterman AL, Lueder DV, Quick M, Myers D, Canagarajah BJ, Phillips MA. Domain organization and a protease-sensitive loop in eukaryotic ornithine decarboxylase. Biochemistry 1995;34:13431-13436.
45. Pegg AE, Shantz LM, Coleman CS. Ornithine decarboxylase: structure, function and translational regulation. Biochem Soc Trans 1994;22:846-852.
46. Wrenger C, Luersen K, Krause T, Muller S, Walter RD. The Plasmodium falciparum bifunctional ornithine decarboxylase, S-adenosylmethionine decarboxylase enables a well balanced polyamine synthesis without domain-domain interaction. J Biol Chem 2001;276:29651-29656.
47. Krause T, Luersen K, Wrenger C, Gilberger TW, Muller S, Walter RD. The ornithine decarboxylase domain of the bifunctional ornithine decarboxylase/S-adenosylemethionine decarboxylase of Plasmodium falciparum: recombinant expression and catalytic properties of two different constructs. Biochem J 2000;352:287-292.
48. Mett H, Standek J, Lopez-Ballester JA, Janne J, Alhonene L, Sinervirta R, Frei J, Renegrass U. Pharmacological properties of the ornithine decarboxylase inhibitor 3-aminooxy-1-propanamine and several structural analogues. Cancer Chemother Pharmacol 1993;32:39-45.
49. Standek J, Frei J, Schneider P, Regenass U. 2-Substituted 3-(aminoozy)propanamines as inhibitors of ornithine decarboxylase: synthesis and biological activity. J Med Chem 1992;35:1339-1344.